Alzheimer's test may miss over half of cases among those with a traumatic brain injury

Publicly released:
International
CC-0
CC-0

Israeli and US scientists say an Alzheimer's test called the plasma phosphorylated tau 217 (p-tau217)/amyloid-β 42 (Aβ42) ratio - which looks at the ratio of two Alzheimer's-linked proteins, tau and beta amyloid - appears to be less accurate among patients who have experienced traumatic brain injuries (TBI) in the past. To determine the test's accuracy, they looked at 272 US veterans, and found the test was highly accurate among people with no history of TBI, but markedly less accurate in those who had experienced TBI. They calculated that, among people with a TBI, the test might miss over half of cases. The findings suggest TBI may modify the chemical signals in the body that the test measures, affecting its accuracy, the authors conclude.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Neurology
Research:Paper
Organisation/s: Sheba Medical Center, Israel
Funder: This work was funded in part by grant W81XWH-21-PRARP-ADRA from the US Department of Defense Congressionally Directed Medical Research Program Peer-Reviewed Alzheimer’s Research Program (Dr Gardner); grant P30AG066518 from the US National Institute of Health National Institute on Aging (Drs Hantke, Silbert, and Schwartz); and grant P30AG062422 from the National Institute on Aging (Drs Vrillon, Blazhenets, Soleimani-Meigooni, and La Joie).
Media Contact/s
Contact details are only visible to registered journalists.